Pricing Log in Create free account

NRx Pharmaceuticals, Inc. (NRXP) vs OnKure Therapeutics, Inc. (OKUR)

NRx Pharmaceuticals, Inc. and OnKure Therapeutics, Inc. are both Biotechnology companies. NRx Pharmaceuticals, Inc. and OnKure Therapeutics, Inc. are of similar size ($102.3M and $98.3M). OnKure Therapeutics, Inc. has the higher net margin (0.00% vs −691.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, NRx Pharmaceuticals, Inc. leads on 6 and OnKure Therapeutics, Inc. on 6.

Valuation

Metric NRXP OKUR Biotechnology median
P/E n/m n/m 10.26
P/S 25.62 n/m 9.18
P/B n/m 0.73 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.82 0.65
EV/Sales 19.36 n/m 8.98
Earnings yield (23.81%) (138.34%) (34.89%)
Free cash flow yield (23.77%) (37.94%) (24.52%)

Profitability

Metric NRXP OKUR Biotechnology median
Gross margin 46.64% 0.00% 65.16%
Operating margin (586.15%) 0.00% 0.00%
Net margin (691.78%) 0.00% 0.00%
Free cash flow margin (609.02%) 0.00% 0.00%
Return on equity 131.22% (46.91%) (50.12%)
Return on assets (120.41%) (44.24%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXP OKUR Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 43.22% 71.20% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXP OKUR Biotechnology median
Debt to equity (2.42) 0.00 0.00
Current ratio 0.86 26.75 4.89
Net debt to EBITDA 0.48 0.95 1.01

Dividend

Metric NRXP OKUR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NRXP OKUR Biotechnology median
Market cap 98.28m 102.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack